Search

everythinglearnresearchcommunity

for

Search:↓

Most women with excess hair growth have an underlying hormonal issue, often treated with medication and hair removal methods.

Targeted cancer therapies often cause serious skin problems that need careful management.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Finasteride treats enlarged prostate and may help with baldness, but effects on sexual function and male fetuses are unclear.

Bone Morphogenetic Proteins (BMPs) help control skin health, hair growth, and color, and could potentially be used to treat skin and hair disorders.

Oestrogens are key for bone growth during puberty in both boys and girls.

Demodicosis is common and often missed, needing more recognition and treatment in skin care.

Mostly postmenopausal Caucasian women get Frontal Fibrosing Alopecia, which often includes eyebrow loss and has limited treatment success.

Chemotherapy-induced hair loss significantly affects patients' well-being, and nurses are key in helping them cope, but more research is needed to find effective treatments.

Androgens can cause hair growth in some areas and hair loss on the scalp.

Lichen planus is a skin condition that can resolve on its own, is linked to hepatitis C, and increases the risk of skin cancer.

Methotrexate treats various disorders by inhibiting DNA synthesis, but careful monitoring is needed to avoid toxicity and manage side effects.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

Superficial granulomatous pyoderma is a unique, mild form of skin disease that often heals without strong medication and responds well to milder treatments.

Silver can help prevent and treat infections but its effectiveness varies and should be weighed against costs and side effects.

Laser hair removal effectiveness depends on targeting hair structures without harming the skin, and improvements require more research and expert collaboration.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

The document concludes that accurate diagnosis of ichthyosis is crucial for treatment and genetic advice, and ongoing research is needed for better therapies.

Some drugs can cause hair loss or increase hair growth, but these effects are usually reversible when the drug is stopped.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

The enzyme 25 Hydroxyvitamin D 1 α-Hydroxylase is essential for healthy skin and recovery after skin damage.

Transplant success has improved with better immunosuppressive drugs and donor matching.

In Italian patients with lupus, the most common skin issue was chronic cutaneous lupus, especially discoid lesions, and nonspecific skin problems occurred in about a third of those with systemic lupus, mainly during active disease.

Early detection and intensive treatment of diseases caused by Staphylococcus aureus toxins are crucial for reducing severe health effects.

Oxidative stress contributes to hair graying and loss as we age.

The document concludes that understanding hair structure is key to diagnosing hair abnormalities and recommends gentle hair care for management.

Janus kinase inhibitors are promising treatments for autoimmune skin diseases like eczema and psoriasis.

Dexamethasone speeds up hair loss in mice, while cyclosporin A slows it down.

The telogen phase of hair growth is active and important for preparing hair follicles for regeneration, not just a resting stage.